|
COMMERCE BUSINESS DAILY ISSUE OF JUNE 3,1999 PSA#2359Director, USAMRAA, 820 Chandler St, Fort Detrick, MD 21702-5014 A -- DOD NEUROFIBROMATOSIS RESEARCH SOL CBD-NFR-0699 DUE 091599 POC
Craig D. Lebo, Contracting Officer The Fiscal Year (FY) 1999 Defense
Appropriations Act provides funds to continue the Department of Defense
Neurofibromatosis Research Program (NFRP) administered by the U.S. Army
Medical Research and Materiel Command (USAMRMC) through the
Congressionally Directed Medical Research Programs (CDMRP).
Approximately $9.3 million will be available to fund neurofibromatosis
research. The central theme of the NFRP is the support of
peer-reviewed innovative research working toward the understanding,
diagnosis, and treatment of neurofibromatosis as well as enhancing the
quality of life for persons with the disease. The USAMRMC is
challenging the scientific community to design innovative research that
will foster new directions for, address neglected issues in, and bring
new investigators into the field of neurofibromatosis research. As in
previous years, the central goal of the NFRP is to support research
with a strong potential to improve treatment of neurofibromatosis. The
programmatic strategy for the FY 99 NFRP is to fund proposals in four
Research Award categories. These consist of Idea Awards, New
Investigator Awards, Investigator-Initiated Awards, and Clinical Trial
Awards. The intent of both New Investigator and Idea Awards is to
stimulate and reward creative research efforts that may be viewed as
speculative but have the potential for high payoff. The CDMRP is
particularly interested in preparing new scientists for careers in
neurofibromatosis research and presenting an opportunity to move
established investigators into the neurofibromatosis field. The intent
of the Investigator-Initiated Research Awards is to sponsor basic
research relevant to neurofibromatosis. Finally, the USAMRMC is
currently soliciting the submission of Clinical Trial Award proposals
of phase I or phase II clinical trials for NF1 or NF2. Significant
execution milestones for this year's program are: Release of the NFRP
Announcement -- early June, 1999; Proposal receipt -- September 15,
1999; Notification of awards -- beginningin January 2000; Award
negotiations completed by September 30, 2000. The NFRP Announcement can
be downloaded from the Congressionally Directed Medical Research
Programs' website, http://cdmrp.army.mil on its release date. The
announcement can also be requested by fax, at (301) 682-5521, or by
phone, at (301) 682-5517, ext. 101. Posted 06/01/99 (W-SN337485).
(0152) Loren Data Corp. http://www.ld.com (SYN# 0007 19990603\A-0007.SOL)
A - Research and Development Index Page
|
|